By Press release submission |
Jun 28, 2022
Since the onset of the COVID-19 pandemic, Indiana University professor James Glazier has been focusing his research on creating a digital twin of the immune system, which could offer precision medicine for a wide array of ailments, including cancer, autoimmune diseases and viral infections such as COVID-19.